GSI 255 (Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg)
Generic Name: emtricitabine/rilpivirine/tenofovir alafenamide
Pill imprint GSI 255 has been identified as Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg.
Odefsey is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Odefsey emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg is classified as a Schedule U controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- emtricitabine/rilpivirine/tenofovir alafenamide
- GSI 255
- emtricitabine 200 mg / rilpivirine 25 mg / tenofovir alafenamide 25 mg
- Prescription only
- Drug Class:
- Antiviral combinations
- CSA Schedule:
- U - Unknown
- Gilead Sciences, Inc.
More about Odefsey (emtricitabine / rilpivirine / tenofovir alafenamide)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 1 Review – Add your own review/rating
- Drug class: antiviral combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.